New research suggests that patients who stop using new GLP-1 drugs like Wegovy and Mounjaro can put back on reduced body mass at a significantly accelerated pace than those who end traditional diet and exercise programs.
Research printed in a major health publication demonstrates that while obese individuals frequently drop a large proportion of their body weight while on the medication, the mass is regained at an estimated rate of nearly a kilo each month once they quit.
"Users buying such treatments should be informed of the potential of quick rebound weight gain when the therapy is stopped," stated expert Dr. Susan Jebb.
This pace of recovery means a return to starting weight within about a year and a half.
Comparing Therapies
The analysis, which reviewed 37 of studies involving over 9,000 of patients, compared the effects of GLP-1 agonists with older methods.
Researchers emphasize that individuals who lose weight through lifestyle changes alone typically have a slower weight regain—perhaps 100 grams monthly—once they finish.
Understanding the Rapid Regain
Experts suggest the way of the jabs is key to understanding the amplified weight return.
The injections copy a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Sustained high doses of GLP-1 concentrations several times higher than the body's typical production could lead to the body to produce less of its endogenous GLP-1, and may also reduce sensitivity to its effects," explained Dr. Adam Collins, a dietetics researcher.
"Stopping of this hormone supplement leads to hunger is no longer kept in check, making excessive eating a significant risk."
A Chronic Issue?
The NHS recommend the jabs for people with weight-linked health risks, accompanied by prescribed lifestyle changes.
A number of clinicians say that, given the high risk of relapse, the therapy should be considered ongoing.
This perspective is reinforced by pharmaceutical companies, who state that the findings "underscore the long-term character of obesity," similar to managing diseases like hypertension.
User Accounts
Individuals who have come off the medication explain a powerful resurgence of cravings.
"It felt as if something that goes on and you're instantly ravenous," said an individual.
This difficulty is compounded if users have not established sustainable lifestyle or habit modifications during therapy.
Significant Interest
Recent estimates indicate that a significant number of people in the UK have used weight-loss jabs in the past year, with demand continuing to grow.
- Adoption is more common among women compared to men.
- The 40s and 50s demographic shows the greatest level of interest.
- A large proportion obtain the medications through private prescriptions rather than public health services.
In conclusion, researchers emphasize that while the jabs are effective agents for shedding pounds, they are not a magic solution and long-term success likely depends on combined lifestyle changes.
